221 related articles for article (PubMed ID: 27234029)
21. Drug repositioning framework by incorporating functional information.
Wu Z; Wang Y; Chen L
IET Syst Biol; 2013 Oct; 7(5):188-94. PubMed ID: 24067419
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel therapeutic properties of drugs from transcriptional responses based on multi-label classification.
Xie L; He S; Wen Y; Bo X; Zhang Z
Sci Rep; 2017 Aug; 7(1):7136. PubMed ID: 28769090
[TBL] [Abstract][Full Text] [Related]
23. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
Jin G; Wong ST
Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
[TBL] [Abstract][Full Text] [Related]
24. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
Wang X; Yan R
J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
[TBL] [Abstract][Full Text] [Related]
25. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
[TBL] [Abstract][Full Text] [Related]
26. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles.
Kim IW; Jang H; Kim JH; Kim MG; Kim S; Oh JM
Sci Rep; 2019 Feb; 9(1):2660. PubMed ID: 30804389
[TBL] [Abstract][Full Text] [Related]
27. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
[TBL] [Abstract][Full Text] [Related]
28. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
29. An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.
Mullen J; Cockell SJ; Woollard P; Wipat A
PLoS One; 2016; 11(5):e0155811. PubMed ID: 27196054
[TBL] [Abstract][Full Text] [Related]
30. GREP: genome for REPositioning drugs.
Sakaue S; Okada Y
Bioinformatics; 2019 Oct; 35(19):3821-3823. PubMed ID: 30859178
[TBL] [Abstract][Full Text] [Related]
31. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.
He J; Yan H; Cai H; Li X; Guan Q; Zheng W; Chen R; Liu H; Song K; Guo Z; Wang X
J Transl Med; 2017 Sep; 15(1):198. PubMed ID: 28962576
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
33. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
34. NetPro: Neighborhood Interaction-Based Drug Repositioning via Label Propagation.
Huang Y; Bin Y; Zeng P; Lan W; Zhong C
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):2159-2169. PubMed ID: 37018341
[TBL] [Abstract][Full Text] [Related]
35. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
36. [Data-driven drug discovery for drug repurposing].
Saito R; Yano N; Kojima S; Miyoshi F
Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
[TBL] [Abstract][Full Text] [Related]
37. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
[TBL] [Abstract][Full Text] [Related]
38. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
[TBL] [Abstract][Full Text] [Related]
39. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
[TBL] [Abstract][Full Text] [Related]
40. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]